18F-FET-PET-based dose painting by numbers with protons

Strahlentherapie und Onkologie

Volumn 186, Issue 6, 2010, Pages 320-326

  Rickhey, Mark ^a   Morávek, Zdenek ^a   Eilles, Christoph ^a   Koelbl, Oliver ^a   Bogner, Ludwig ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

18F FET PET; Biological imaging; Dose painting; IMPT; IMRT; Modulation transfer function; Photons; Protons

Indexed keywords

FLUORINE 18; FLUOROETHYLTYROSINE; PROTON; TRACER; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; O (2 ((18)F)FLUOROETHYL) L TYROSINE; O-(2-((18)F)FLUOROETHYL)-L-TYROSINE; TYROSINE;

ALGORITHM; ARTICLE; BRAIN TUMOR; CASE REPORT; CLINICAL TRIAL; DOSE CALCULATION; FEASIBILITY STUDY; GLIOBLASTOMA; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MODULATION TRANSFER FUNCTION; MONTE CARLO METHOD; NEUROIMAGING; PHOTON; POSITRON EMISSION TOMOGRAPHY; PRESCRIPTION; RADIATION DOSE; RISK; TREATMENT PLANNING; TUMOR CELL; COMPUTER ASSISTED RADIOTHERAPY; LINEAR ENERGY TRANSFER; METHODOLOGY;

ALGORITHMS; BRAIN NEOPLASMS; FLUORINE RADIOISOTOPES; GLIOBLASTOMA; HUMANS; LINEAR ENERGY TRANSFER; MONTE CARLO METHOD; PHOTONS; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TYROSINE;

EID: 77953977959     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2014-8     Document Type: Article

References (36)

1. Alber M, Paulsen F, Eschmann SM, et al. On biologically conformai boost dose optimization. Phys Med Biol 2003;48: N31-5. (Pubitemid 36204163)
2. Baumert BG, Norton IA, Lomax AJ, et al. Dose conformation of intensitymodulated stereotactic photon beams, proton beams, and intensitymodulated proton beams for intracranial lesions. Int J Radiat Oncol Biol Phys 2004;60: 1314-1324
3. Bogner L, Hartmann M, Rickhey M, et al. Application of an inverse kernel concept to Monte Carlo based IMRT. Med Phys 2006;33: 4749-4757
4. Bortfeld T. An analytical approximation of the Bragg curve for therapeutic proton beams. Med Phys 1997;24: 2024-2033
5. Burnet NG, Jena R, Jefferies SJ, et al. Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol (R Coll Radiol) 2006;18: 93-103.
6. Chao KS, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001;49: 1171-1182
7. Del Sole A, Falini A, Ravasi L, et al. Anatomical and biochemical investigation of primary brain tumours. Eur J Nucl Med 2001;28: 1851-1872
8. Fio rino C, Dell'Oca I, Pierelli A, et al. Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study. Strahlenther Onkol 2007;183: 497-505.
9. Fippel M. Fast Monte Carlo dose calculation for photon beams based on the VMC electron algorithm. Med Phys 1998;26: 1446-1475
10. Fippel M, Haryanto F, Dohm O, et al. A virtual photon energy fluence model for Monte Carlo dose calculation. Med Phys 2003;30: 301-311
11. Fippel M, Soukup M. A Monte Carlo dose calculation algorithm for proton therapy. Med Phys 2004;31: 2263-2273
12. Flynn RT, Barbee DL, Mackie TR, et al. Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study. Phys Med Biol 2007;52: 6073-6091
13. Flynn RT, Bowen SR, Bentzen SM, et al. Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. Phys Med Biol 2008;53: 4153-4167
14. Georg D, Georg P, Hillbrand M, et al. Assessment of improved organ at risk sparing for advanced cervix carcinoma utilizing precision radiotherapy techniques. Strahlenther Onkol 2008;184: 586-591
15. Hall EJ. Dose-painting by numbers: a feasible approach? Lancet Oncol 2005;6: 66.
16. Heistercamp C, Haatanen T, Schild SE, et al. Dose escalation in patients receiving whole-brain therapy for brain metastases from colorectal cancer. Strahlenther Onkol 2010;186: 70-75
17. Illiadis G, Selviaridis P, Kalogera-Fountzila A, et al. The importance of tumor volume in the prognosis of patients with glioblastoma. Comparison of computerized volumetry and geometric models. Strahlenther Onkol 2009;185: 734-750
18. Karger CP, Jäkel O. Current status and new developments in ion therapy. Strahlenther Onkol 2007;183: 295-300.
19. Kocher M, Frommolt P, Borberg S, et al. Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma. Strahlenther Onkol 2008;184: 572-579
20. 18F] fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2006;33: 287-294
21. Morávek Z, Bogner L. 354 inverse kernel optimisation for the spot-scanning proton radiotherapy. Radiother Oncol 2005;76:Suppl 2:5159-5160
22. Pauleit D, Stoffels G, Bachofner A, et al. Comparison of (18)F-FET and (18JF-FDG PET in brain tumors. Nucl Med Biol 2009;36: 779-787
23. Pedroni E, Scheib S, Böhringer T, et al. Experimental characterization and physical modelling of the dose distribution of scanned proton pencil beams. Phys Med Biol 2005;50: 541-561
24. Piroth M, Gagel B, Pinkawa M, et al. Postoperative radiotherapy of glioblastoma multiforme. Analysis and critical assessment of different treatment strategies and predictive factors. Strahlenther Onkol 2007;183: 695-702.
25. Popped G, Kreth F, Mehrkens J, et al. FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging 2007;34: 1933-1942
26. Rickhey M, Bogner L. Application of the inverse Monte Carlo treatment planning system IKO for an inhomogeneous dose prescription in the sense of dose painting. Z Med Phys 2006;16: 307-312
27. 18F-FET-PET in brain tumors. Strahlenther Onkol 2008;184: 536-542
28. Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol 2006;80: 263-267
29. Sterzing F, Welzel T, Sroka-Perez G, et al. Reirradiation of multiple brain metastases with helical tomotherapy. A multifocal simultaneous integrated boost for eight or more lesions. Strahlenther Onkol 2009;185: 89-93.
30. Taheri-Kadkhoda Z, Bjork-Eriksson T, Nill S, et al. Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons. Radiat Oncol 2008;3: 4.
31. Thorwarth D, Soukup M, AlberM. Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison. Radiother Oncol 2008;86: 30-34
32. Vandecasteele K, De Neve W, De Gersem W, et al. Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementation. Strahlenther Onkol 2008;185: 799-807.
33. Vanderstraeten B, Duthoy W, De Gersem W, et al. [(18)F]fluoro-deoxy- glucose positron emission tomography ([(18JF] FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother Oncol 2006;79: 249-258
34. Wang C, Nakayama H, Sugahara T, et al. Comparisons of dose-volume histograms for proton-beam versus 3-D conformai X-ray therapy in patients with stage I non-small cell lung cancer. Strahlenther Onkol 2008;185: 231-234
35. Weber DC, Trofimov AV, Delaney TF, et al. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int J Radiât Oncol Biol Phys 2004;58: 1596-1606
36. 11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 2000;27: 542-549